BIOVECTRA signs service agreement with Acuitas Therapeutics for unique lipid nanoparticle (LNP) delivery system used in manufacturing mRNA-based therapies Post author: Post published:October 6, 2023 Post category:uncategorized BIOVECTRA and Acuitas Therapeutics, Inc. today announced that they have entered into a technology transfer service. You Might Also Like New drug restores vision by regenerating retinal nerves April 1, 2025 Mini-protein AKY-1189 delivers targeted radiation to tumor cells October 24, 2024 TOMI Environmental Solutions supports partners and customers to combat global avian influenza (H5N1) bird flu outbreak June 19, 2024
TOMI Environmental Solutions supports partners and customers to combat global avian influenza (H5N1) bird flu outbreak June 19, 2024